Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
CareDx
Market Cap: US$892.0m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$16.10
7D
4.6%
1Y
8.9%
Nutex Health
Market Cap: US$877.9m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$173.76
7D
44.0%
1Y
2,258.6%
Pharvaris
Market Cap: US$875.7m
A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
PHVS
US$15.91
7D
-6.6%
1Y
-26.7%
STAAR Surgical
Market Cap: US$863.0m
Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
STAA
US$18.29
7D
-6.3%
1Y
-57.1%
Extendicare
Market Cap: CA$1.2b
Through its subsidiaries, provides care and services for seniors in Canada.
EXE
CA$14.52
7D
2.3%
1Y
99.5%
AMN Healthcare Services
Market Cap: US$833.5m
Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.
AMN
US$22.38
7D
10.1%
1Y
-62.1%
HealthStream
Market Cap: US$826.6m
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
HSTM
US$27.57
7D
1.2%
1Y
0.9%
Avadel Pharmaceuticals
Market Cap: US$825.2m
Operates as a biopharmaceutical company in the United States.
AVDL
US$8.89
7D
-5.3%
1Y
-44.2%
Intellia Therapeutics
Market Cap: US$816.2m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$8.08
7D
-2.5%
1Y
-69.1%
SI-BONE
Market Cap: US$799.0m
A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
SIBN
US$18.88
7D
3.0%
1Y
24.8%
Syndax Pharmaceuticals
Market Cap: US$798.5m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$8.95
7D
-18.7%
1Y
-57.2%
Niagen Bioscience
Market Cap: US$797.3m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.50
7D
13.6%
1Y
201.7%
Cronos Group
Market Cap: CA$1.1b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.92
7D
5.0%
1Y
-29.5%
CorMedix
Market Cap: US$788.1m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$11.69
7D
-2.8%
1Y
124.8%
Ardelyx
Market Cap: US$784.8m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.38
7D
-7.1%
1Y
-56.6%
Zymeworks
Market Cap: US$783.9m
A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).
ZYME
US$11.53
7D
1.9%
1Y
22.9%
LENZ Therapeutics
Market Cap: US$777.7m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$27.34
7D
5.7%
1Y
65.4%
CureVac
Market Cap: US$758.8m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$3.43
7D
-4.6%
1Y
-1.6%
Geron
Market Cap: US$757.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.21
7D
-4.0%
1Y
-69.0%
Praxis Precision Medicines
Market Cap: US$755.7m
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
PRAX
US$37.20
7D
-2.3%
1Y
-17.7%
Bicara Therapeutics
Market Cap: US$747.1m
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$14.47
7D
10.2%
1Y
n/a
WELL Health Technologies
Market Cap: CA$1.0b
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.
WELL
CA$4.12
7D
5.9%
1Y
6.7%
Xeris Biopharma Holdings
Market Cap: US$743.1m
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$4.79
7D
-7.2%
1Y
137.1%
Nuvation Bio
Market Cap: US$738.4m
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$2.24
7D
6.7%
1Y
-34.3%
Nurix Therapeutics
Market Cap: US$730.3m
A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
NRIX
US$9.46
7D
-1.9%
1Y
-38.6%
Veradigm
Market Cap: US$712.6m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.45
7D
-0.9%
1Y
-43.3%
Anavex Life Sciences
Market Cap: US$697.5m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$8.37
7D
-2.2%
1Y
86.0%
Immunome
Market Cap: US$693.5m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$8.00
7D
3.8%
1Y
-44.4%
uniQure
Market Cap: US$692.3m
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE
US$13.25
7D
8.2%
1Y
161.3%
Embecta
Market Cap: US$677.3m
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
EMBC
US$11.66
7D
-12.3%
1Y
-17.9%
Nika Pharmaceuticals
Market Cap: US$672.8m
Engages in the development and distribution of various pharmaceutical products.
NIKA
US$0.66
7D
n/a
1Y
-6.1%
Curaleaf Holdings
Market Cap: CA$931.6m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.24
7D
2.5%
1Y
-83.9%
Akebia Therapeutics
Market Cap: US$667.1m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$2.54
7D
-0.4%
1Y
120.9%
IRADIMED
Market Cap: US$660.0m
Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.
IRMD
US$53.86
7D
2.3%
1Y
26.3%
PolyNovo
Market Cap: AU$1.0b
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
PNV
AU$1.49
7D
1.7%
1Y
-32.5%
Mesa Laboratories
Market Cap: US$652.6m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$121.35
7D
-3.3%
1Y
0.6%